Zoledronic acid for treament of prostate cancer
Dr. Thomas W. Leonard, Chief Scientific Officer, Merrion Pharmaceuticals
25 Jun 2009
AACR 2009: Circulating tumour cells as biomarkers
Dr Howard Scher - Sloan Kettering Memorial Cancer Center
5 Jun 2009
AACR 2009: Common genetic variations and predisposition to cancer
Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
14 May 2009
AACR 2009: Chemokine inhibitors to prevent tumour growth
Prof Alberto Mantovani - Professor of General Pathology, University of Milan
14 May 2009
AACR 2009: 100 years of AACR
Dr Margaret Foti - CEO of the American Association for Cancer Research
14 May 2009
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours
Prof Gabriele Bergers - University of California, San Francisco
14 May 2009
AACR 2009: DNA profiling for bladder cancer
Dr Gangning Liang - Associate Professor of Research, Department of Urology, Univ...
30 Apr 2009
AACR 2009: Genetic prostate cancer risk
Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA
30 Apr 2009
AACR 2009: Designer T-Cells tackle prostate cancer
Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston...
30 Apr 2009
Bacteria as agents to initiate potent anti-tumour activity
Dr Maria Rescigno - Deptartment of Experimental Oncology, European Institute of ...
31 Mar 2009
ECCO 15 - ESMO 34 Executive Scientific Programme Committee
ECCO-ESMO Roundtable discussion - Full Version
16 Feb 2009
10 new genes increase risk of breast cancer
Professor Douglas Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridg...
12 Jan 2009
